异位表达的化特异性癌症丸抗原HORMAD1促进状细胞癌中的基因组不稳定性
Jennifer Gantchev1, Julia Messina-Pacheco1,2, Amelia Martínez Villarreal1
1Research Institute of McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
状细胞癌 (SCCs) 的基因组不稳定性与弥解蛋白HORMAD1.1有关. 通过向这一关键蛋白质,抑制HORMAD1可能提供新的癌症治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 基因组不稳定性是癌症的关键标志,但其驱动因素尚未完全理解.
- 介质变异特异性基因和介质变异异的异位表达在具有高基因组不稳定的癌症中被观察到.
- 介质变异特异性基因是癌症治疗的潜在治疗标.
研究的目的:
- 为了研究变蛋白HORMAD1在状细胞癌 (SCCs) 中基因组不稳定的作用.
- 探索HORMAD1表达水平与SCC中的DNA损伤/修复途径之间的关系.
- 确定针对HORMAD1或其在SCC中的调节途径的潜在治疗策略.
主要方法:
- 在HORMAD1敲除和过度表达后,在SCC细胞系中评估DNA损伤和基因组不稳定性标记.
- 利用shRNA减少HORMAD1的表达,并分析对细胞过程的影响.
- 研究了HORMAD1的上游调控途径,包括转录因子STRA8.
主要成果:
- HORMAD1 枯竭增加了基因组的不稳定性,DNA 损伤和埃托胺敏感性,同时降低了DNA 损伤反应/修复基因表达.
- 过度表达HORMAD1会产生保护作用,减少DNA损伤,提高生存率,降低埃托胺的敏感性.
- 通过转录因子STRA8确定了通过转录因子STRA8调节HORMAD1的介质途径.
结论:
- 在SCCs中,HORMAD1表达和基因组不稳定性之间存在显著的相关性.
- 针对HORMAD1,可能通过STRA8信号传递,为表达HORMAD1的SCCs提供了一种新的治疗方法.
- 了解HORMAD1-STRA8轴为特定癌症类型提供了新的治疗范式.
更多相关视频
12:49Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders
Published on: September 4, 2011
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
相关概念视频
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Nondisjunction
Mutagenicity and Carcinogenicity
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
